These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 31220258)

  • 1. Reassessing the dosing of cefoxitin prophylaxis during major abdominal surgery: insights from microdialysis and population pharmacokinetic modelling.
    Boisson M; Torres BGS; Yani S; Couet W; Mimoz O; Dahyot-Fizelier C; Marchand S; Grégoire N
    J Antimicrob Chemother; 2019 Jul; 74(7):1975-1983. PubMed ID: 31220258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and tissue penetration of cefoxitin in obesity: implications for risk of surgical site infection.
    Toma O; Suntrup P; Stefanescu A; London A; Mutch M; Kharasch E
    Anesth Analg; 2011 Oct; 113(4):730-7. PubMed ID: 21642605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrated pharmacokinetic-pharmacodynamic modelling to evaluate antimicrobial prophylaxis in abdominal surgery.
    Zelenitsky SA; Lawson C; Calic D; Ariano RE; Roberts JA; Lipman J; Zhanel GG
    J Antimicrob Chemother; 2016 Oct; 71(10):2902-8. PubMed ID: 27402005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Population pharmacokinetics of prophylactic cefoxitin in elective bariatric surgery patients: a prospective monocentric study.
    Novy E; Liu X; Hernández-Mitre MP; Belveyre T; Scala-Bertola J; Roberts JA; Parker SL
    Anaesth Crit Care Pain Med; 2024 Jun; 43(3):101376. PubMed ID: 38494157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic and Pharmacodynamic Evaluation of a Weight-Based Dosing Regimen of Cefoxitin for Perioperative Surgical Prophylaxis in Obese and Morbidly Obese Patients.
    Moine P; Mueller SW; Schoen JA; Rothchild KB; Fish DN
    Antimicrob Agents Chemother; 2016 Oct; 60(10):5885-93. PubMed ID: 27458209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Population pharmacokinetics of prophylactic cefoxitin in patients undergoing colorectal surgery.
    Isla A; Trocóniz IF; de Tejada IL; Vázquez S; Canut A; López JM; Solinís MÁ; Rodríguez Gascón A
    Eur J Clin Pharmacol; 2012 May; 68(5):735-45. PubMed ID: 22246211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Higher versus Lower Dose of Cefotetan or Cefoxitin for Surgical Prophylaxis in Patients Weighing One Hundred Twenty Kilograms or More.
    Banoub M; Curless MS; Smith JM; Jarrell AS; Cosgrove SE; Rock C; Avdic E
    Surg Infect (Larchmt); 2018 Jul; 19(5):504-509. PubMed ID: 29717917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacodynamic modelling of intravenous antibiotic prophylaxis in elective colorectal surgery.
    Moine P; Fish DN
    Int J Antimicrob Agents; 2013 Feb; 41(2):167-73. PubMed ID: 23182539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Population Pharmacokinetics of Cefoxitin Administered for Pediatric Cardiac Surgery Prophylaxis.
    Ricci Z; Benegni S; Cies JJ; Marinari E; Haiberger R; Garisto C; Rizza A; Giorni C; Di Chiara L; Arpicco S; Muntoni E; Ferrari F; Milla P
    Pediatr Infect Dis J; 2020 Jul; 39(7):609-614. PubMed ID: 32221166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cefoxitin Plasma and Subcutaneous Adipose Tissue Concentration in Patients Undergoing Sleeve Gastrectomy.
    Brunetti L; Kagan L; Forrester G; Aleksunes LM; Lin H; Buyske S; Nahass RG
    Clin Ther; 2016 Jan; 38(1):204-10. PubMed ID: 26686826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic antibiotic prophylaxis prior to gastrointestinal surgery - is oral administration of doxycycline and metronidazole adequate?
    Giske A; Nymo LS; Fuskevåg OM; Amundsen S; Simonsen GS; Lassen K
    Infect Dis (Lond); 2017; 49(11-12):785-791. PubMed ID: 28657405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of cefotaxime plus metronidazole versus cefoxitin for prevention of wound infection after abdominal surgery.
    Kow L; Toouli J; Brookman J; McDonald PJ
    World J Surg; 1995; 19(5):680-6; discussion 686. PubMed ID: 7571663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of the Obesity Phenotype on the Adequacy of Antibiotic Prophylaxis with Cefoxitin for Obese Patients Undergoing Bariatric Surgery: Lessons Learnt and Future Considerations.
    Belveyre T; Scala-Bertola J; Esposito M; Luc A; Lipman J; Novy E
    Eur J Drug Metab Pharmacokinet; 2021 Jul; 46(4):479-485. PubMed ID: 33959888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Continuous versus intermittent infusion of prophylactic cefoxitin after colorectal surgery: a pilot study.
    Suffoletta TJ; Jennings HR; Oh JJ; Stephens D; Poe KL
    Pharmacotherapy; 2008 Sep; 28(9):1133-9. PubMed ID: 18752384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. First-dose and steady-state population pharmacokinetics and pharmacodynamics of piperacillin by continuous or intermittent dosing in critically ill patients with sepsis.
    Roberts JA; Kirkpatrick CM; Roberts MS; Dalley AJ; Lipman J
    Int J Antimicrob Agents; 2010 Feb; 35(2):156-63. PubMed ID: 20018492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacodynamic model for β-lactam regimens used in surgical prophylaxis: model-based evaluation of standard dosing regimens.
    Song X; Long M
    Int J Clin Pharm; 2018 Oct; 40(5):1059-1071. PubMed ID: 30117081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacious Cefazolin Prophylactic Dose for Morbidly Obese Women Undergoing Bariatric Surgery Based on Evidence from Subcutaneous Microdialysis and Populational Pharmacokinetic Modeling.
    Palma EC; Meinhardt NG; Stein AT; Heineck I; Fischer MI; de Araújo B; Dalla Costa T
    Pharm Res; 2018 Apr; 35(6):116. PubMed ID: 29644481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preoperative intraparietal (intra-incisional) cefoxitin in abdominal surgery.
    Taylor TV; Walker WS; Mason RC; Richmond J; Lee D
    Br J Surg; 1982 Aug; 69(8):461-2. PubMed ID: 7049308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibiotic regimen and the timing of prophylaxis are important for reducing surgical site infection after elective abdominal colorectal surgery.
    Ho VP; Barie PS; Stein SL; Trencheva K; Milsom JW; Lee SW; Sonoda T
    Surg Infect (Larchmt); 2011 Aug; 12(4):255-60. PubMed ID: 21790479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of three-dose cefoxitin prophylaxis in caesarean section.
    Roex AJ; Van Loenen AC
    Pharm Weekbl Sci; 1988 Dec; 10(6):281-3. PubMed ID: 3211702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.